Literature DB >> 20979557

Recent advances in the treatment of eosinophilic esophagitis.

Shauna Schroeder1, Dan Atkins, Glenn T Furuta.   

Abstract

First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of the current literature on EoE has been published in the last 3 years, signaling both a rising incidence and increased recognition of this disorder. Treatment options available for patients with EoE include dietary management and/or pharmacologic therapy. An individualized approach to treatment is preferred, with an emphasis on patient-parental preference. The objective of this article is to discuss the current and future treatment options for EoE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979557      PMCID: PMC3816102          DOI: 10.1586/eci.10.65

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  69 in total

1.  Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response.

Authors:  A Straumann; M Bauer; B Fischer; K Blaser; H U Simon
Journal:  J Allergy Clin Immunol       Date:  2001-12       Impact factor: 10.793

Review 2.  Eosinophilic esophagitis: it's not just kid's stuff.

Authors:  Victor L Fox; Samuel Nurko; Glenn T Furuta
Journal:  Gastrointest Endosc       Date:  2002-08       Impact factor: 9.427

3.  Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis.

Authors:  H Korsapati; A Babaei; V Bhargava; R Dohil; A Quin; R K Mittal
Journal:  Gut       Date:  2009-01-09       Impact factor: 23.059

4.  The role of allergy evaluation in adults with eosinophilic esophagitis.

Authors:  Joshua D Penfield; David M Lang; John R Goldblum; Rocio Lopez; Gary W Falk
Journal:  J Clin Gastroenterol       Date:  2010-01       Impact factor: 3.062

Review 5.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

6.  Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate.

Authors:  Jonathan E Teitelbaum; Victor L Fox; Frank J Twarog; Samuel Nurko; Don Antonioli; Gerald Gleich; Kamran Badizadegan; Glenn T Furuta
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

7.  IL-5 promotes eosinophil trafficking to the esophagus.

Authors:  Anil Mishra; Simon P Hogan; Eric B Brandt; Marc E Rothenberg
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

8.  Eosinophilic gastroenteritis: our recent experience: one-year experience of atypical onset of an uncommon disease.

Authors:  E Redondo-Cerezo; M J Cabello; Y González; M Gómez; M García-Montero; J de Teresa
Journal:  Scand J Gastroenterol       Date:  2001-12       Impact factor: 2.423

9.  Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.

Authors:  A Straumann; S Conus; P Grzonka; H Kita; G Kephart; C Bussmann; C Beglinger; D A Smith; J Patel; M Byrne; H-U Simon
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

10.  Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis.

Authors:  M Vicario; C Blanchard; K F Stringer; M H Collins; M K Mingler; A Ahrens; P E Putnam; J P Abonia; J Santos; M E Rothenberg
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

View more
  1 in total

1.  Clinical presentation and treatment of pediatric patients with eosinophilic esophagitis.

Authors:  Chris A Liacouras
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.